Xtrackers MSCI World Value ESG UCITS ETF (XWEV) Share Price

I still find it hard to believe that ENTA is trading at a $130 million market cap, with a negative enterprise value! All while it’s competing with major pharmaceutical companies in developing treatments for COVID, HBV, and RSV—and is even leading in certain areas. It's really odd.

georgie18,
I read your comments all the time.
I have a question.
Do you know the link or links where I can find the stock symbols for AI stocks?
Also, anyone who has the knowledge can answer.
Thanks.
God Bless You.

Polish patriots remind us that Europe is Christian

https://x.com/RadioGenoa/status/1872202575472418885

https://x.com/MatchPoiint/status/1872202858160074819

Pharma whales soaking up the float
Elevai Labs (ELAB) Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation

December 9, 2024 8:03 AM
Elevai Labs Inc. (Nasdaq: ELAB) (“Elevai” or the “Company”), a diversified

Nicaragua unveils new canal route in bid to rival Panama The canal project would comprise four segments, with President Ortega suggesting it could attract investment from both Chinese and US businesses. / bne IntelliNews
FacebookTwitterLinkedInTelegramFlipboardFeedly
By bne IntelliNews

May be a good idea at these levels ? 🤔

💲AMTD

Well….it appears that the Nicaragua Canal is back in play…… https://www.intellinews.com/nicaragua-unveils-new-canal-route-in-bid-to-rival-panama-354300/

Crypto PRQ explodes to .29. I bought it recently at .12. Why is it lately that the ones I own the least of go up the most? LOL

See? He stuffs his pockets with cash like a good GEO should, and keeps the company alive. That's genius.

I agree with you. I'm not sure where shareholder confidence ranks, but the reality is surely not what it should or could be. Hopefully things course correct, as I hope for great things to transpire.

Note: Shareholder confidence is often a valuable KPI.

This brings t

I have IonQ that closed today at another new high.

Looking for a continuation of what happened today also tomorrow- in both AI and Quantum stocks!

We got used to this type of thing, didn't we? lol. We like it!

GLTY & GLTA

Dream on, fool. I have been onto this, the third scam, (if not the fourth, as SAEI was suspiciously similar) since before gitreal was on iHub. Like him, I have NEVER been wrong in calling a natural resource pink stock a scam. This one is that and more.... and is the worst MOASSS ever. You're gonna n

Charles Schwab won't allow trading anymore in this company.

Thanks to Chris and company for all the wonderful stories in the past......

This was just a brisk walk to .83 today‼️

$Tay tune for the Moon run once volume is here‼️

Apparently the Muppet doesn't understand what Vivos meant when they clearly stated,..."This milestone trial, which has commenced with the successful treatment of five patients with cancerous lymph nodes, represents a transformative step in advancing innovative cancer therapies.".

Hi

Interesting check in chart that makes me laugh.

One could choose either interpretation:

1. Long Tail Up since 23-Dec-2024. This is negative and suggest price is likely to correct.

2.. Histogram bars pointing to likely recovery in share price.

Hobbs & Fontes rigged 2 consecutive elections against Kari Lake

https://x.com/Real_RobN/status/1871965421470912693

you think AI is hot have a look at quantum

or they get (impo) approval the price explodes and shorts are destroyed.

End of the day...You, nor I, know what is coming. I am far more calm than you are.


That's what I am confident of

58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.

58% of Americans aged 65 and older have only $100,000 or less in their 401(k)s, per GoBankingRates.

Yes, I'm enjoying the discussions. Yes, EDP 235 may never get a phase 3 trial- OTOH, if covid vaccinations continue to decline and IF another Delta like covid variant were to become prevalent we might wish we had a better drug than Paxlovid. And in spite of Paxlovid's possible inferiority to other c